Stelis Biopharma

Activities: Manufacturing Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Finance

Stelis Biopharma appoints Mark W. Womack as CEO

Before joining Stelis, Womack was the Chief Business Officer for AGC Biologics
Manufacturing

RDIF and Stelis partner to supply Sputnik V vaccine doses

The agreement covers 200 million doses of the Sputnik V vaccine, which is enough to vaccinate 100 million individuals
Finance

Stelis starts next phase of facility investment

This phase will see the company start work on installing two 2,000L single-use bioreactor trains in its mammalian CGMP facility
Manufacturing

Stelis Biopharma begins construction of US$60m multiproduct biologics facility in Malaysia

Will incorporate the latest single-use bioreactor systems for scale-up and process development
Subscribe now